curative radiotherapy is given for patients with tumours that would ordinarily be operable but are in fact inoperable for medical reasons, or are of low bulk but in a difficult site, and in a single radiotherapy field which may safely receive a high dose
radiotherapy is more effective for peripheral (coin) lesions than for central tumours
protocols are generally based on daily treatments over a period of four to six weeks, although it is possible that this may be altered to continuous hyperfractionated radiotherapy if current trials are successful
radical radiotherapy results in a 2-3% 5 year survival rate
radiotherapy to the mediastinum and primary tumour site after a good, ideally complete, response to chemotherapy leads to a further increased chance of long-term survival in small-cell lung cancers
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.